ConductScience.org, home

Paper39337461

New Insights into Mitochondria in Health and Diseases.

Li Y and 9 others. Int J Mol Sci, 2024. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. New Insights into Mitochondria in Health and Diseases. Papers, record 39337461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337461

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New Insights into Mitochondria in Health and Diseases.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
7.83, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li YYa
2Zhang HHuhu
3Yu CChunjuan
4Dong XXiaolei
5Yang FFanghao
6Wang MMengjun
7Wen ZZiyuan
8Su MMohan
9Li BBing
10Yang LLina

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MitochondriaMajor topic
Mitochondrial DiseasesMajor topic
Humans
Animals
Neoplasms
Energy Metabolism
Reactive Oxygen Species

Source PubMed

References127

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,321,555Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis.EMBO Mol Med2022https://conductscience.org/library/papers/36321555PubMed
237,047,492Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review.Int J Mol Sci2023https://conductscience.org/library/papers/37047492PubMed
335,851,420Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.J Hematol Oncol2022https://conductscience.org/library/papers/35851420PubMed
434,122,299Leber Hereditary Optic Neuropathy: Review of Treatment and Management.Front Neurol2021https://conductscience.org/library/papers/34122299PubMed
519,204,268Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation.Neurology2009https://conductscience.org/library/papers/19204268PubMed
635,682,884AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension.Int J Mol Sci2022https://conductscience.org/library/papers/35682884PubMed
71,576,071A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia.Br J Clin Pharmacol1992https://conductscience.org/library/papers/1576071PubMed
827,259,056The Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England.Am J Hum Genet2016https://conductscience.org/library/papers/27259056PubMed
916,604,074High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.Nat Genet2006https://conductscience.org/library/papers/16604074PubMed
1038,982,016Mitochondrial targeted antioxidants as potential therapy for huntington's disease.Pharmacol Rep2024https://conductscience.org/library/papers/38982016PubMed
1127,930,341Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/27930341PubMed
1238,286,821Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation.Nat Metab2024https://conductscience.org/library/papers/38286821PubMed
1327,814,641The little big genome: the organization of mitochondrial DNA.Front Biosci (Landmark Ed)2017https://conductscience.org/library/papers/27814641PubMed
1420,871,098Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy.Hum Mol Genet2010https://conductscience.org/library/papers/20871098PubMed
1516,399,671Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.J Neurosci2006https://conductscience.org/library/papers/16399671PubMed
1636,810,524Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions.Signal Transduct Target Ther2023https://conductscience.org/library/papers/36810524PubMed
1721,806,499Mechanisms of mitochondrial diseases.Ann Med2012https://conductscience.org/library/papers/21806499PubMed
1823,422,877Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8.Neurochem Int2013https://conductscience.org/library/papers/23422877PubMed
1937,923,251Elamipretide Topical Ophthalmic Solution for the Treatment of Subjects with Leber Hereditary Optic Neuropathy: A Randomized Trial.Ophthalmology2024https://conductscience.org/library/papers/37923251PubMed
2028,004,807Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.Nat Rev Cardiol2017https://conductscience.org/library/papers/28004807PubMed

See all 127 references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42,942,175Mitochondrial Genomic Variation in Rare and Metabolic Diseases: From Heteroplasmy to Precision Medicine.Life (Basel)2026https://conductscience.org/library/papers/42942175PubMed
42,866,626Recent Advances in Mitochondria-Targeted Delivery Strategies for Ischemic Stroke Therapy.Int J Nanomedicine2026https://conductscience.org/library/papers/42866626PubMed
42,524,031Eplerenone Attenuates Hepatic Oxidative Stress and Mitochondrial Dysfunction Following Renal Ischemia-Reperfusion Injury in Rats.Adv Pharm Bull2026https://conductscience.org/library/papers/42524031PubMed
42,346,399Identification and Transcriptomic Analysis of Mitochondria-Related Gene Signatures in Obesity.Metabolites2026https://conductscience.org/library/papers/42346399PubMed
42,136,573Molecular pathways, tissue-specific roles, and therapeutic opportunities in mitochondrial resilience-based strategies for insulin resistance.Front Clin Diabetes Healthc2026https://conductscience.org/library/papers/42136573PubMed
42,068,434Hepatoprotective Mechanisms of Lactiplantibacillus plantarum SCS7 Cell-Free Extract Against Aflatoxin B1 Toxicity.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/42068434PubMed
41,963,964Mitochondrial dysfunction in neonatal brain injury: from molecular mechanisms to therapeutic interventions.J Transl Med2026https://conductscience.org/library/papers/41963964PubMed
41,854,947Beyond Supportive Care: Mitochondria as a Strategic Therapeutic Avenue in Acute Pancreatitis.Dig Dis Sci2026https://conductscience.org/library/papers/41854947PubMed
41,827,730Metal Ion-Mediated Regulation of Cell Fate: A Novel Strategy for Synergy with Radiotherapy and Immunotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/41827730PubMed
41,816,588Identification of mitochondrial-related subtypes and development of a prognostic model for pancreatic ductal adenocarcinoma.J Gastrointest Oncol2026https://conductscience.org/library/papers/41816588PubMed
41,503,358No effect of pyrroloquinoline quinone on mouse body weight and energy metabolism with the concomitant increase in mitochondrial biogenesis and antioxidant ability.Metabol Open2026https://conductscience.org/library/papers/41503358PubMed
41,496,907The pivotal role of mitochondria in osteoporosis: From pathogenesis to future therapies.Biochem Biophys Rep2026https://conductscience.org/library/papers/41496907PubMed
41,439,139Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging.Genes Dis2026https://conductscience.org/library/papers/41439139PubMed
41,393,082Mitochondria-Targeted Nanosystems in the Treatment of Central Nervous System Diseases.Int J Nanomedicine2025https://conductscience.org/library/papers/41393082PubMed
41,240,149Mitochondrial Calcium Channels and MAM Interaction in Calcium Homeostasis Dysregulation in Parkinson's Disease.Neurochem Res2025https://conductscience.org/library/papers/41240149PubMed
41,030,279Mitochondrial and photosynthetic therapy: A crucial strategy for remodeling cellular metabolic function.Bioeng Transl Med2025https://conductscience.org/library/papers/41030279PubMed
41,029,932Mitochondria as a Therapeutic Target in Metabolic Disorders.Mini Rev Med Chem2026https://conductscience.org/library/papers/41029932PubMed
40,997,805The multiomics blueprint of the individual with the most extreme lifespan.Cell Rep Med2025https://conductscience.org/library/papers/40997805PubMed
40,701,842Hemistepsin A induces apoptosis by modulating the reactive oxygen species-dependent PI3K/Akt signaling pathway in human lung carcinoma A549 cells.Korean J Physiol Pharmacol2025https://conductscience.org/library/papers/40701842PubMed
40,516,788Analysis of mitochondrial membrane potential, ROS, and calcium.Mol Cells2025https://conductscience.org/library/papers/40516788PubMed

See all 25 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39337461

GET https://conductscience.org/api/papers/v1/39337461/references?page=2